Atlas Trials

A Study in Participants With Non-cirrhotic NASH With Fibrosis

Clinical trial NCT05638737 · COMPLETED

Trial details

NCT number
NCT05638737
Sponsor
AstraZeneca
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Non-Cirrhotic Non-alcoholic Steatohepatitis With Fibrosis
Start date
2022-10-26
Primary completion
2024-04-04
Enrollment
112

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.